Nonclassic congenital adrenal hyperplasia
- PMID: 20671993
- PMCID: PMC2910408
- DOI: 10.1155/2010/625105
Nonclassic congenital adrenal hyperplasia
Abstract
Nonclassic congenital adrenal hyperplasia (NCAH) due to P450c21 (21-hydroxylase deficiency) is a common autosomal recessive disorder. This disorder is due to mutations in the CYP21A2 gene which is located at chromosome 6p21. The clinical features predominantly reflect androgen excess rather than adrenal insufficiency leading to an ascertainment bias favoring diagnosis in females. Treatment goals include normal linear growth velocity and "on-time" puberty in affected children. For adolescent and adult women, treatment goals include regularization of menses, prevention of progression of hirsutism, and fertility. This paper will review key aspects regarding pathophysiology, diagnosis, and treatment of NCAH.
References
-
- Decourt J, Jayle MF, Baulieu E. Virilisme cliniquement tardif avec excrétion de prégnanetriol et insuffisance de la production du cortisol. Annales d’Endocrinologie. 1957;18(3):416–422. - PubMed
-
- Lutfallah C, Wang W, Mason JI, et al. Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism. 2002;87(6):2611–2622. - PubMed
-
- Joehrer K, Geley S, Strasser-Wozak EMC, et al. CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11β- hydroxylase deficiency. Human Molecular Genetics. 1997;6(11):1829–1834. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
